Narges Farahi, MD
Family Practice · Burlington
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Piedmont Health Services Inc · 38 clinicians in this group
Hospitals listed: Unc Hospitals. That is not proof they admit you there this week.
Research they published
27 papers · cited 148 times
Published as Narges Farahi at University of North Carolina at Chapel Hill.
Research identity is not a guarantee of current clinical practice. Same name is not the same person — if this looks like someone else, tell us.
| 2026 | Implementing an adapted patient safety bundle for pregnancy-related severe hypertension to improve recognition, response, and respectful care in the outpatient setting | Implementation Science Communications |
| 2025 | “Making our voices count”: patient action groups as a strategy to engage people with lived experience in implementation of an intervention for hypertensive disorders of pregnancy | Frontiers in Health Services |
| 2025 | Understanding barriers and facilitators to implementation of a patient safety bundle for pregnancy-related severe hypertension in 3 North Carolina outpatient clinics: a qualitative study | Implementation Science Communications |
| 2024 | Community-engaged implementation of a safety bundle for pregnancy-related severe hypertension in the outpatient setting: protocol for a type 3 hybrid study with a multiple baseline design | BMC Health Services Research |
| 2024 | Hypertensive Disorders of Pregnancy.First author | PubMed |
| 2024 | Birthing Parent Experiences of Postpartum at-Home Blood Pressure Monitoring Versus Office-Based Follow up After Diagnosis of Hypertensive Disorders of Pregnancy | Journal of Patient Experience |
See the 16 most recent papers
| 2023 | Implementation research priorities for addressing the maternal health crisis in the USA: results from a modified Delphi study among researchers | Implementation Science Communications |
| 2022 | Correlates of Receiving Guideline-Concordant Postpartum Health Services in the Community Health Center Setting | Women s Health Reports |
| 2022 | Reply to “Comparison of Maternity Care Training in Family Medicine Residencies 2013 and 2019: A CERA Program Directors Study”Last author | Family Medicine |
| 2021 | Sexual Assault of Women.First author | PubMed |
| 2020 | Collaborative Practice and Teaching in Perinatal Care: Certified Nurse‐Midwives as Educators of Medical Residents | Journal of Midwifery & Women s Health |
| 2020 | Certified Nurse Midwives as Teachers of Family Medicine ResidentsFirst author | Family Medicine |
| 2019 | Improved Breastfeeding Outcomes Following an On-site Support Intervention in an Academic Family Medicine Center | Family Medicine |
| 2019 | Time to conception after miscarriage: How long to wait?First author | PubMed |
| 2016 | PURLs: Aneuploidy screening: Newer noninvasive test gains traction. | PubMed |
| 2013 | Recommendations for preconception counseling and care.First author | PubMed |
Topics: Pregnancy and preeclampsia studies · Health Policy Implementation Science · Maternal and Perinatal Health Interventions · Reproductive Health and Contraception · Clinical practice guidelines implementation
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Farahi’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A108699 · Cancelled
Licence status: Cancelled · since 2009 · University of Pittsburgh School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Unc HospitalsChapel Hill, NCAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of UNC Health Care System, which runs 15 hospitalsHome of UNC Lineberger Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.685, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.606, Oct 2024 – Sep 2025
See every measure and the patient survey for Unc Hospitals
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 5 better, 6 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.685 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.606 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.77 (0.02 to 1.52) · 2,693 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.71 to 1.12) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 161.89 (128.51 to 195.27) · 264 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.4 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 408 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.1 · 405 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 493 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,907 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.13 to 0.49) · 10,696 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.15 to 0.5) · 11,495 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.29 (1.79 to 4.79) · 3,768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.04 (0 to 2.24) · 1,925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (1.06 to 3.17) · 3,512 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.88 (4.9 to 12.87) · 1,760 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.44 (1.13 to 5.76) · 1,918 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.52 (0.22 to 2.82) · 1,003 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.71 (0.29 to 1.12) · 9,900 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 189 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.018 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.697 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.637 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.796 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 399 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.8 · 897 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -10.4 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -12.4 · 451 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5.8 · 428 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 14.5 · 698 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.8 (4.6 to 7.2) · 922 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.8 (8.2 to 11.7) · 922 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.6 · 184 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.9 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 334 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.8 (8.4 to 13.9) · 2,091 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 1,351 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,558 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Medicaid work
$1,144 in 2024
Medicaid paid $1,144 for 14 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 14 | $1,144 |
| 2024 | 14 | 1 | 13 | $1,144 |
| 2023 | 53 | 1 | 13 | $6,475 |
| 2022 | 87 | 1 | 14 | $10,455 |
| 2021 | 147 | 3 | 21 | $16,106 |
| 2020 | 100 | 4 | 18 | $8,443 |
| 2019 | 76 | 3 | 18 | $7,192 |
| 2018 | 162 | 5 | 19 | $8,807 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 53 | $6,475 |
2022
| Clinic visit/encounter, all-inclusive | 87 | $10,455 |
2021
| Clinic visit/encounter, all-inclusive | 97 | $11,857 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 32 | $2,906 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 18 | $1,342 |
2020
| Clinic visit/encounter, all-inclusive | 41 | $3,786 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 31 | $2,900 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 14 | $1,251 |
| Subsequent hospital care, per day, for evaluation and management of normal newborn | 14 | $506 |
2019
| Clinic visit/encounter, all-inclusive | 37 | $4,152 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 24 | $2,097 |
| Return visit (30+ min) | 15 | $943 |
2018
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 55 | $4,049 |
| Return visit (30+ min) | 65 | $2,971 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 17 | $1,169 |
| Short return visit (20+ min) | 12 | $591 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 13 | $27 |
Drugs they prescribed that Part D paid
$205,373
Pharmacies billed $205,373 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (21 of 855) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 52% of their opioid prescriptions.
699 generic and fewer than 11 brand-name prescriptions · $205,373 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 14 | $23,754 | $1,697 |
| Buprenorphine-Naloxone | 16 | $1,988 | $124 |
| Duloxetine | 25 | $991 | $40 |
| Potassium Citrate Er | 13 | $597 | $46 |
| Albuterol Sulfate Hfa | 18 | $550 | $31 |
See all 23 drugs
| Jardiance | 14 | $23,754 | $1,697 |
| Buprenorphine-Naloxone | 16 | $1,988 | $124 |
| Duloxetine | 25 | $991 | $40 |
| Potassium Citrate Er | 13 | $597 | $46 |
| Albuterol Sulfate Hfa | 18 | $550 | $31 |
| Atorvastatin | 58 | $495 | $9 |
| Celecoxib | 17 | $449 | $26 |
| Metformin Hcl Er | 21 | $369 | $18 |
| Losartan | 43 | $355 | $8 |
| Morphine Sulfate Er | 11 | $302 | $27 |
| Amlodipine Besylate | 38 | $288 | $8 |
| Metoprolol | 14 | $287 | $20 |
| Pregabalin | 23 | $284 | $12 |
| Gabapentin | 17 | $262 | $15 |
| Omeprazole | 20 | $182 | $9 |
| Fluticasone Propionate | 19 | $156 | $8 |
| Lisinopril | 23 | $127 | $6 |
| Sertraline | 16 | $122 | $8 |
| Trazodone | 18 | $91 | $5 |
| Hydrochlorothiazide | 19 | $50 | $3 |
| Donepezil | 11 | $49 | $4 |
| Zolpidem | 12 | $48 | $4 |
| Pantoprazole | 11 | $26 | $2 |
Year by year
| 2024 | 855 | 89 | 3% (21) | None | $205,373 |
| 2023 | 793 | 85 | 3% (20) | 15% | $123,367 |
| 2022 | 747 | 74 | 3% (24) | 14% | $112,062 |
| 2021 | 660 | 66 | 7% (46) | 13% | $62,206 |
| 2020 | 714 | 62 | 6% (43) | 16% | $68,353 |
| 2019 | 817 | 54 | 8% (67) | 19% | $70,880 |
| 2018 | 797 | 51 | 6% (49) | 16% | $46,702 |
| 2017 | 716 | 45 | 3% (23) | 14% | $30,855 |
| 2016 | 1,053 | 50 | 3% (31) | 16% | $49,405 |
| 2015 | 1,245 | 67 | 2% (28) | 28% | $88,941 |
| 2014 | 1,476 | 90 | 3% (38) | 26% | $95,270 |
| 2013 | 583 | 60 | 5% (30) | None | $30,806 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Ozempic | 18 | $17,992 | $1,000 |
| Duloxetine | 22 | $2,339 | $106 |
| Buprenorphine-Naloxone | 17 | $856 | $50 |
| Atorvastatin | 55 | $791 | $14 |
| Metoprolol | 29 | $667 | $23 |
| Pregabalin | 20 | $633 | $32 |
| Losartan | 42 | $517 | $12 |
| Metformin Hcl Er | 26 | $446 | $17 |
| Gabapentin | 22 | $434 | $20 |
| Fluticasone Propionate | 19 | $409 | $22 |
| Amlodipine Besylate | 37 | $285 | $8 |
| Morphine Sulfate Er | 11 | $255 | $23 |
| Lisinopril | 20 | $157 | $8 |
| Rosuvastatin | 13 | $147 | $11 |
| Levothyroxine | 16 | $132 | $8 |
| Sertraline | 13 | $130 | $10 |
| Hydrochlorothiazide | 21 | $87 | $4 |
| Fluconazole | 13 | $81 | $6 |
| Zolpidem | 12 | $60 | $5 |
2022: 19 drugs
| Jardiance | 13 | $18,492 | $1,422 |
| Buprenorphine-Naloxone | 13 | $1,941 | $149 |
| Atorvastatin | 60 | $668 | $11 |
| Gabapentin | 21 | $443 | $21 |
| Fluticasone Propionate | 15 | $405 | $27 |
| Metoprolol | 17 | $383 | $23 |
| Losartan | 49 | $341 | $7 |
| Amlodipine Besylate | 42 | $314 | $7 |
| Metformin Hcl Er | 33 | $211 | $6 |
| Pregabalin | 15 | $211 | $14 |
| Oxycodone | 13 | $208 | $16 |
| Levothyroxine | 13 | $186 | $14 |
| Montelukast | 11 | $169 | $15 |
| Sertraline | 13 | $143 | $11 |
| Lisinopril | 18 | $84 | $5 |
| Furosemide | 16 | $79 | $5 |
| Hydrochlorothiazide | 23 | $73 | $3 |
| Zolpidem | 12 | $54 | $4 |
| Clonazepam | 11 | $29 | $3 |
2021: 13 drugs
| Atorvastatin | 42 | $646 | $15 |
| Metoprolol | 15 | $600 | $40 |
| Duloxetine | 16 | $593 | $37 |
| Morphine Sulfate Er | 23 | $552 | $24 |
| Gabapentin | 26 | $430 | $17 |
| Losartan | 32 | $370 | $12 |
| Pregabalin | 11 | $302 | $27 |
| Metformin Hcl Er | 30 | $282 | $9 |
| Amlodipine Besylate | 37 | $253 | $7 |
| Lisinopril | 15 | $223 | $15 |
| Oxycodone | 13 | $193 | $15 |
| Clonazepam | 13 | $114 | $9 |
| Metoprolol | 11 | $113 | $10 |
2020: 15 drugs
| Eliquis | 15 | $15,320 | $1,021 |
| Gabapentin | 19 | $1,015 | $53 |
| Atorvastatin | 54 | $749 | $14 |
| Morphine Sulfate Er | 24 | $587 | $24 |
| Duloxetine | 12 | $477 | $40 |
| Metoprolol | 11 | $437 | $40 |
| Metformin Hcl Er | 28 | $386 | $14 |
| Potassium Chloride | 13 | $345 | $27 |
| Amlodipine Besylate | 35 | $338 | $10 |
| Quinapril | 12 | $284 | $24 |
| Losartan | 36 | $277 | $8 |
| Lisinopril | 26 | $273 | $10 |
| Sertraline | 11 | $185 | $17 |
| Furosemide | 20 | $103 | $5 |
| Metoprolol | 15 | $35 | $2 |
2019: 20 drugs
| Eliquis | 16 | $10,237 | $640 |
| Incruse Ellipta | 12 | $6,089 | $507 |
| Xtampza Er | 12 | $5,782 | $482 |
| Ventolin Hfa | 17 | $1,208 | $71 |
| Gabapentin | 23 | $1,087 | $47 |
| Duloxetine | 15 | $1,081 | $72 |
| Atorvastatin | 61 | $982 | $16 |
| Potassium Chloride | 14 | $866 | $62 |
| Metoprolol | 14 | $637 | $45 |
| Morphine Sulfate Er | 24 | $587 | $24 |
| Metformin Hcl Er | 33 | $470 | $14 |
| Amlodipine Besylate | 47 | $425 | $9 |
| Hydrocodone-Acetaminophen | 15 | $365 | $24 |
| Losartan | 35 | $225 | $6 |
| Lisinopril | 29 | $221 | $8 |
| Sertraline | 23 | $181 | $8 |
| Furosemide | 18 | $113 | $6 |
| Triamterene-Hydrochlorothiazid | 13 | $77 | $6 |
| Simvastatin | 11 | $56 | $5 |
| Metoprolol | 23 | $55 | $2 |
2018: 24 drugs
| Lyrica | 19 | $8,841 | $465 |
| Lantus | 12 | $5,186 | $432 |
| Advair Diskus | 12 | $4,976 | $415 |
| Duloxetine | 13 | $1,180 | $91 |
| Atorvastatin | 76 | $1,054 | $14 |
| Ventolin Hfa | 17 | $931 | $55 |
| Potassium Chloride | 13 | $783 | $60 |
| Gabapentin | 21 | $453 | $22 |
| Mirtazapine | 11 | $434 | $39 |
| Amlodipine Besylate | 75 | $428 | $6 |
| Morphine Sulfate Er | 14 | $408 | $29 |
| Metoprolol | 11 | $401 | $36 |
| Quinapril | 21 | $377 | $18 |
| Metformin Hcl Er | 17 | $324 | $19 |
| Hydrocodone-Acetaminophen | 11 | $307 | $28 |
| Losartan | 23 | $195 | $8 |
| Lisinopril | 32 | $177 | $6 |
| Sertraline | 19 | $173 | $9 |
| Furosemide | 25 | $155 | $6 |
| Lisinopril-Hydrochlorothiazide | 12 | $92 | $8 |
| Pantoprazole | 14 | $86 | $6 |
| Triamterene-Hydrochlorothiazid | 12 | $83 | $7 |
| Hydrochlorothiazide | 12 | $63 | $5 |
| Paroxetine | 12 | $56 | $5 |
2017: 18 drugs
| Duloxetine | 19 | $1,275 | $67 |
| Metoprolol | 19 | $865 | $46 |
| Atorvastatin | 72 | $793 | $11 |
| Ventolin Hfa | 13 | $692 | $53 |
| Gabapentin | 28 | $362 | $13 |
| Polyethylene Glycol 3350 | 13 | $320 | $25 |
| Metformin Hcl Er | 27 | $290 | $11 |
| Quinapril | 16 | $279 | $17 |
| Tamsulosin | 14 | $254 | $18 |
| Amlodipine Besylate | 54 | $242 | $4 |
| Losartan | 27 | $208 | $8 |
| Amitriptyline | 17 | $148 | $9 |
| Fluticasone Propionate | 12 | $142 | $12 |
| Lisinopril-Hydrochlorothiazide | 17 | $133 | $8 |
| Lisinopril | 24 | $110 | $5 |
| Hydrochlorothiazide | 28 | $92 | $3 |
| Paroxetine | 12 | $49 | $4 |
| Furosemide | 14 | $49 | $3 |
2016: 31 drugs
| Oxycontin | 11 | $3,020 | $275 |
| Duloxetine | 18 | $1,086 | $60 |
| Potassium Chloride | 13 | $1,002 | $77 |
| Metoprolol | 19 | $920 | $48 |
| Atorvastatin | 84 | $828 | $10 |
| Ventolin Hfa | 14 | $730 | $52 |
| Venlafaxine Hcl Er | 23 | $713 | $31 |
| Gabapentin | 30 | $611 | $20 |
| Insulin | 12 | $581 | $48 |
| Polyethylene Glycol 3350 | 14 | $460 | $33 |
| Amlodipine Besylate | 96 | $434 | $5 |
| Hydrocodone-Acetaminophen | 11 | $347 | $32 |
| Quinapril | 18 | $345 | $19 |
| Oxybutynin Chloride | 13 | $263 | $20 |
| Losartan | 46 | $257 | $6 |
| Metformin Hcl Er | 32 | $252 | $8 |
| Diltiazem Er | 12 | $228 | $19 |
| Tamsulosin | 12 | $195 | $16 |
| Levothyroxine | 14 | $180 | $13 |
| Isosorbide Mononitrate Er | 13 | $177 | $14 |
| Sertraline | 25 | $162 | $6 |
| Fluticasone Propionate | 16 | $148 | $9 |
| Lisinopril | 37 | $147 | $4 |
| Hydrochlorothiazide | 47 | $142 | $3 |
| Amitriptyline | 16 | $123 | $8 |
| Omeprazole | 13 | $100 | $8 |
| Simvastatin | 14 | $97 | $7 |
| Furosemide | 24 | $75 | $3 |
| Carvedilol | 11 | $51 | $5 |
| Fluoxetine | 11 | $31 | $3 |
| Lorazepam | 11 | $15 | $1 |
2015: 40 drugs
| Lantus | 19 | $33,689 | $1,773 |
| Novolog Flexpen | 17 | $16,564 | $974 |
| Nexium | 16 | $6,632 | $414 |
| Duloxetine | 14 | $1,400 | $100 |
| Proair Hfa | 33 | $1,323 | $40 |
| Potassium Chloride | 31 | $1,140 | $37 |
| Atorvastatin | 82 | $1,115 | $14 |
| Diltiazem Er | 16 | $738 | $46 |
| Insulin | 15 | $724 | $48 |
| Metoprolol | 15 | $625 | $42 |
| Gabapentin | 26 | $500 | $19 |
| Sucralfate | 18 | $494 | $27 |
| Amlodipine Besylate | 83 | $432 | $5 |
| Venlafaxine Hcl Er | 13 | $371 | $29 |
| Oxycodone-Acetaminophen | 12 | $360 | $30 |
| Pravastatin | 12 | $356 | $30 |
| Quinapril | 20 | $345 | $17 |
| Losartan | 50 | $337 | $7 |
| Glipizide Xl | 20 | $293 | $15 |
| Sertraline | 43 | $286 | $7 |
| Metformin Hcl Er | 21 | $278 | $13 |
| Levothyroxine | 20 | $256 | $13 |
| Polyethylene Glycol 3350 | 13 | $251 | $19 |
| Isosorbide Mononitrate Er | 18 | $162 | $9 |
| Omeprazole | 18 | $155 | $9 |
| Hydrochlorothiazide | 49 | $147 | $3 |
| Lisinopril | 29 | $136 | $5 |
| Allopurinol | 12 | $128 | $11 |
| Donepezil | 12 | $122 | $10 |
| Trazodone | 20 | $113 | $6 |
| Metformin | 13 | $109 | $8 |
| Furosemide | 39 | $108 | $3 |
| Fluoxetine | 22 | $107 | $5 |
| Amitriptyline | 12 | $103 | $9 |
| Atenolol-Chlorthalidone | 11 | $100 | $9 |
| Mirtazapine | 11 | $96 | $9 |
| Atenolol | 11 | $79 | $7 |
| Lovastatin | 14 | $61 | $4 |
| Simvastatin | 11 | $54 | $5 |
| Lorazepam | 12 | $30 | $2 |
2014: 40 drugs
| Lantus | 16 | $18,257 | $1,141 |
| Nexium | 36 | $13,252 | $368 |
| Spiriva | 13 | $3,335 | $257 |
| Proair Hfa | 40 | $1,453 | $36 |
| Metoprolol | 31 | $1,029 | $33 |
| Insulin | 18 | $912 | $51 |
| Fluoxetine | 37 | $837 | $23 |
| Omeprazole | 52 | $758 | $15 |
| Gabapentin | 42 | $753 | $18 |
| Polyethylene Glycol 3350 | 18 | $746 | $41 |
| Potassium Chloride | 17 | $556 | $33 |
| Bd Ultra-Fine Pen Needle | 16 | $550 | $34 |
| Losartan | 44 | $496 | $11 |
| Oxybutynin Chloride | 15 | $486 | $32 |
| Venlafaxine Hcl Er | 19 | $452 | $24 |
| Sucralfate | 18 | $389 | $22 |
| Amlodipine Besylate | 54 | $385 | $7 |
| Quinapril | 19 | $370 | $19 |
| Atorvastatin | 30 | $337 | $11 |
| Levothyroxine | 27 | $332 | $12 |
| Metformin | 35 | $317 | $9 |
| Amitriptyline | 20 | $294 | $15 |
| Enalapril Maleate | 25 | $262 | $10 |
| Sertraline | 27 | $207 | $8 |
| Hydrochlorothiazide | 74 | $206 | $3 |
| Lisinopril | 40 | $205 | $5 |
| Acetaminophen-Codeine | 12 | $203 | $17 |
| Simvastatin | 24 | $167 | $7 |
| Trazodone | 19 | $151 | $8 |
| Lorazepam | 19 | $150 | $8 |
| Fluticasone Propionate | 12 | $138 | $11 |
| Cyclobenzaprine | 14 | $136 | $10 |
| Lovastatin | 18 | $134 | $7 |
| Metformin Hcl Er | 22 | $124 | $6 |
| Losartan-Hydrochlorothiazide | 16 | $107 | $7 |
| Atenolol | 14 | $104 | $7 |
| Isosorbide Mononitrate Er | 14 | $91 | $7 |
| Metoprolol | 22 | $74 | $3 |
| Citalopram Hbr | 12 | $65 | $5 |
| Furosemide | 17 | $39 | $2 |
2013: 12 drugs
| Proair Hfa | 13 | $676 | $52 |
| Omeprazole | 21 | $404 | $19 |
| Losartan | 25 | $359 | $14 |
| Amlodipine Besylate | 22 | $240 | $11 |
| Simvastatin | 22 | $208 | $9 |
| Metformin | 25 | $175 | $7 |
| Isosorbide Mononitrate Er | 17 | $153 | $9 |
| Lisinopril | 21 | $118 | $6 |
| Levothyroxine | 13 | $111 | $9 |
| Hydrochlorothiazide | 33 | $102 | $3 |
| Metoprolol | 12 | $85 | $7 |
| Enalapril Maleate | 13 | $68 | $5 |
Professional record
- NPI
- 1366775090
- Licence
- CA A108699California A108699: Cancelled
- Trained
- University of Pittsburgh School of Medicine, 2007
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 751 S. Bascom Ave, Santa Clara Valley Medical Center, Department of Ob/Gyn, San Jose, CA, 95128
- NPI first listed
- 2009-09-14
- NPI last updated
- 2011-06-06
This is when the NPI record was last certified, not a medical board exam.